DFLI Earnings

DFLI reported its FY2025Q3 earnings on 2025-11-14, showcasing a revenue of 15.97M against an estimate of 15.97M, resulting in a -0.03% surprise. The EPS was -0.2, surpassing the expected -0.71 by 71.83%. The stock experienced a -1.27% price change on the earnings day and a -23.29% change over the next five days, reflecting market reactions to the results.

Following DFLI's FY2025Q3 earnings announcement on 2025-11-14, the stock price moved by -1.27% on the day of the release. Over the subsequent five days, it saw a -23.29% change. Historically, DFLI's stock price tends to shift by an average of 20.18% in the 10 days leading up to earnings and -1.89% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate DFLI's annual revenue to reach 15.03M, while the EPS is projected at -0.30. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between DFLI's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, DFLI's stock price typically moves by 20.18% in the 10 days before its earnings and -1.89% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.30 and revenue of 15.03M.

The earnings call summary reveals concerns: DTC revenue decline, increased operating expenses due to debt restructuring, and continued pressure on revenue and EBITDA loss in early 2026. Despite full-year growth and OEM channel strength, the Q4 results were mixed with margin declines. The Q&A highlighted market challenges and uncertainties, including lithium price volatility and cash burn concerns. While there is optimism for future growth, the current financial health and guidance suggest a negative sentiment, likely leading to a stock price decrease of -2% to -8%.